RUN Hematology
32243296 2020. Essential Role of Patient Blood Management in a Pandemic: A Call for Action
32267830 2020. Blood transfusion during the COVID-19 outbreak
32267829 2020. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and Transfusion Medicine: reflections from Italy
32305078 ä. Blood transfusion strategies and ECMO during the COVID-19 pandemic
32334676 ä. Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries
32237972 2020. Impact of COVID-19 and Future Emerging Viruses on Hematopoietic Cell Transplantation and Other Cellular Therapies
32330288 2020. Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic
32107119 ä. Coronavirus Disease 2019: Coronaviruses and Blood Safety
32147378 ä. COVID-19 and Blood Safety: Help with a Dilemma
{{tp|p=32284222|t=2020. The active role of a blood center in outpacing the transfusion transmission of COVID-19
32297850 ä. Pasteurized blood samples for transfusion compatibility testing during the coronavirus disease 2019 outbreak
32417113 ä. A quick ?Can I donate blood? self-assessment tool amid the COVID-19 outbreak
32386966 ä. The blood supply management amid the COVID-19 outbreak
32418663 ä. Cold Plasma, a New Hope in the Field of Virus Inactivation
32348044 2020. L'hematologie au temps du COVID-19
32292885 2020. COVID and hematology: special considerations regarding patient safety, gold standard therapies and safety for health care professionals?
32240543 ä. The impact of the SARS?CoV?2 outbreak on the safety and availability of blood transfusions in Italy
32198754 2020. Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID-19) pandemic affecting Washington State
32280061 2020. COVID-19: Is a paradigm change to be expected in health care and transfusion medicine?
32361996 2020. SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission
32311760 2020. Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment
32240537 2020. Post-donation COVID-19 identification in blood donors
